“…12,13 Additionally, efforts made in health care to prevent COVID-19 transmission, including physical distancing and limited staffing, may delay initiation of hormone therapy 12 and monitoring of its effects. 13 These barriers to gender-affirming care may contribute to increased severity of mental health conditions including depression, anxiety, and psychological distress. Further, COVID-19-related barriers to accessing medications such as pre-exposure prophylaxis may increase the risk of HIV transmission among TGD people, who bear a disproportionate burden of HIV/sexually transmitted infections compared with the U.S. general population.…”